Consistently, previous studies showed that IDH1R132H transduction inhibited rather than stimulated tumor growth [8, 9], and gliomas with IDH1 mutations possessed attenuated oncogenic signaling in comparison with those without [8, 10–13]. The gene discussed is IDH1; the disease is glioma.